Lifeward (LFWD) FCF Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | 33,113.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33,113.00 |
| Dec 31, 2025 | 10,991.00 |
| Sep 30, 2025 | 45,760.00 |
| Jun 30, 2025 | 16,652.00 |
| Mar 31, 2025 | 54,258.00 |
| Dec 31, 2024 | 15,553.00 |
| Sep 30, 2024 | 5,807.00 |
| Jun 30, 2024 | 13,693.00 |
| Mar 31, 2024 | 9,655.00 |
| Dec 31, 2023 | 13,552.00 |
| Sep 30, 2023 | 18,644.00 |
| Jun 30, 2023 | -7,050.00 |
| Mar 31, 2023 | 14,692.00 |
| Dec 31, 2022 | 12,559.00 |
| Sep 30, 2022 | -25,518.00 |
| Jun 30, 2022 | 18,759.00 |
| Mar 31, 2022 | -38,293.00 |
| Dec 31, 2021 | -4,284.00 |
| Sep 30, 2021 | 6,162.00 |
| Jun 30, 2021 | 768.00 |
| Mar 31, 2021 | 7,651.00 |
| Dec 31, 2020 | 15,608.00 |
| Sep 30, 2020 | -1,820.00 |
| Jun 30, 2020 | 6,632.00 |
| Mar 31, 2020 | -33,071.00 |
| Dec 31, 2019 | 10,910.00 |
| Sep 30, 2019 | 21,366.00 |
| Jun 30, 2019 | 41,522.00 |
| Mar 31, 2019 | 7,384.00 |
| Dec 31, 2018 | 38,066.00 |
| Sep 30, 2018 | -70,044.00 |
| Jun 30, 2018 | -119,180.00 |
| Mar 31, 2018 | 71,052.00 |
| Dec 31, 2017 | -17,262.00 |
| Sep 30, 2017 | -71,619.00 |
| Jun 30, 2017 | -101,985.00 |
| Dec 31, 2016 | 29,774.00 |
| Sep 30, 2016 | -102,146.00 |